If You'd Invested $10,000 in Berkshire Hathaway Stock 10 Years Ago, Here's How Much You'd Have Today

Berkshire Hathaway shares rose 240% over the past decade (through Mar 25) versus the S&P 500 total return of 282%, indicating decade-long underperformance. EPS drove gains—Berkshire's EPS increased 218% from 2015–2025—while valuation was stable (P/E 15.4 today vs 14.4 ten years ago). The firm's large cash balance and avoidance of big tech stakes are cited as ongoing drags, and new CEO Greg Abel faces the challenge of closing the performance gap. Motley Fool's Stock Advisor did not include Berkshire in its top 10 picks, underscoring mixed analyst sentiment.

Analysis

Berkshire’s core problem is structural scale and optionality friction: at $hundreds of billions in deployable capital, each incremental dollar must find ever-larger opportunities to move the needle on EPS, which compresses marginal returns compared with high-growth tech winners. That creates a persistent performance gap versus concentrated, high-ROIC tech exposures even when Berkshire’s operating businesses grow steadily; the real second-order winner from that dynamic has been passive and thematic funds that concentrate in a handful of mega-cap tech names, pulling index performance higher.

A management pivot is the primary catalyst that could change trajectory over 6–24 months — specifically, meaningful active deployment of cash into faster-growth equities, aggressive buybacks, or large-scale M&A that leverages insurance float. Conversely, macro shocks (equity drawdowns that erode the investment portfolio) or a reinsurance loss cycle could compress float and force conservative capital preservation, quickly reversing any recovery in relative performance. Regulatory or tax changes that make large equity stakes or buybacks less attractive are a lower-probability but high-impact tail risk over multiple years.

From a positioning standpoint, the market has underpriced two asymmetric scenarios: (1) a decisive capital allocation shift that narrows the gap versus growth indexes, and (2) continued conservative posture that leaves Berkshire as a durable but underperforming large-cap compounder. These map into simple option and pair structures where limited-premium long calls on growth names and put-protection on Berkshire provide concentrated exposure to the catalyst while capping downside on the base case.

Key Decisions for Investors

• Pair trade (12-month horizon): Short BRKB (equal-dollar) vs Long NVDA (equal-dollar). Position size: net 2–3% portfolio risk. Rationale: capture re-rating divergence if tech continues to outperform while scale constrains BRK; set stop-loss if the pair moves 10% adverse on a relative basis, target 20–30% relative return.
• Asymmetric option play (6–9 months): Buy NVDA 6–9m 25% OTM calls (size 0.5–1% of portfolio) financed by selling a small amount of near-term call premium on a liquid non-core holding. Rationale: low-cost exposure to continued tech leadership; payoffs >3x if catalyst runs; limit premium loss to allocated size.
• Tail-hedge on conglomerate risk (9–12 months): Buy BRKB 12m put spread (e.g., 15%/30% strikes) sized to cap downside to 1–2% portfolio risk, financed by selling a higher strike call or using a smaller notional. Rationale: protects against sudden mark-to-market losses from the investment portfolio or underwriting shocks while keeping cost contained.
• Event speculation (quarterly monitoring): If management announces >$10bn buybacks or large tech stake within next 6 months, rotate 50–75% of pair short exposure into outright BRKB long (12–24m) to capture re-rating; set profit-taking at 50% of position gains and reassess governance signals.